U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Medical Devices
  3. Medical Devices News and Events
  4. Webinar - Electromagnetic Compatibility (EMC) of In Vitro Diagnostic Devices - 02/02/2023
  1. Medical Devices News and Events

Webcast | Virtual

Event Title
Webinar - Electromagnetic Compatibility (EMC) of In Vitro Diagnostic Devices
February 2, 2023

Date:
February 2, 2023
Time:
1:00 p.m. - 2:00 p.m. ET

Summary

On February 2, 2023, the U.S. Food and Drug Administration (FDA) hosted a webinar for interested stakeholders to discuss the final guidance Electromagnetic Compatibility (EMC) of Medical Devices and its applicability to in vitro diagnostic (IVD) devices and respond to questions. 

During this webinar the FDA:

  • Clarified recommendations for electromagnetic compatibility information to include in an IVD premarket submission.
  • Helped manufacturers and FDA staff use the FDA-recognized standards and partially recognized standards for the evaluation of electromagnetic compatibility of IVDs.

Background

This final guidance, Electromagnetic Compatibility (EMC) of Medical Devices, was issued on June 6, 2022. This guidance document provides the FDA’s recommendations on testing to assess the electromagnetic compatibility of medical devices and information to include in the labeling. This guidance applies to medical devices, including IVDs, and accessories that are electrically powered or have functions or sensors that are implemented using electrical or electronic circuitry. The recommendations are intended to promote consistency and facilitate efficient review of electromagnetic compatibility in device submissions.

Webinar Materials

The presentation, printable slides, and transcript are available at CDRH Learn under “In Vitro Diagnostics.”

If you have questions about this guidance document, please contact seth.seidman@fda.hhs.gov. If you have questions about this webinar, please contact CDRH's Division of Industry and Consumer Education (DICE) at dice@fda.hhs.gov, 1-800-638-2041, or 301-796-7100.

Back to Top